Follow
John F Forbes
John F Forbes
Professor of Surgical Oncology University of Newcastle
Verified email at anzbctg.org
Title
Cited by
Cited by
Year
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 365 (9472), 1687-1717, 2005
77252005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
61442005
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
42752013
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 351 (9114), 1451-1467, 1998
39611998
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ...
Lancet 365 (9453), 60-62, 2005
29552005
Genome-wide association study identifies novel breast cancer susceptibility loci
DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ...
Nature 447 (7148), 1087-1093, 2007
27752007
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial
AW Bradbury, CV Ruckley, FGR Fowkes, JF Forbes, I Gillespie, DJ Adam
Lancet 366 (9501), 1925-1934, 2005
24412005
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
C Davies, H Pan, J Godwin, R Gray, R Arriagada, V Raina, M Abraham, ...
The Lancet 381 (9869), 805-816, 2013
24252013
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
22162015
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
21551998
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC …
A The
The Lancet 359 (9324), 2131-2139, 2002
20892002
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
Breast International Group (BIG) 1-98 Collaborative Group
New England Journal of Medicine 353 (26), 2747-2757, 2005
19572005
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009
A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn
Annals of oncology 20 (8), 1319-1329, 2009
19522009
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women …
P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, R Gray, ...
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2014
1846*2014
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
12652015
Overview of the main outcomes in breast-cancer prevention trials
J Cuzick, T Powles, U Veronesi, J Forbes, R Edwards, S Ashley, P Boyle
The Lancet 361 (9354), 296-300, 2003
12472003
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
AS Coates, A Keshaviah, B Thürlimann, H Mouridsen, L Mauriac, ...
Journal of clinical oncology 25 (5), 486-492, 2007
11472007
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
J Cuzick, I Sestak, M Baum, A Buzdar, A Howell, M Dowsett, JF Forbes
The lancet oncology 11 (12), 1135-1141, 2010
11302010
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
T Arimidex
The lancet oncology 9 (1), 45-53, 2008
10972008
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
RC Coombes, LS Kilburn, CF Snowdon, R Paridaens, RE Coleman, ...
The Lancet 369 (9561), 559-570, 2007
10902007
The system can't perform the operation now. Try again later.
Articles 1–20